Patent ID: 6994853

Claim:
A method for inducing immunity against a tumor in a patient, comprising administering to the patient in a time-staggered manner: (1) autologous tumor cells or allogeneic tumor cells of the same tumor type each treated to prevent their survival after reinfusion; and (2) intact bispecific and/or trispecific antibodies having the following properties of: (a) binding to a T cell; (b) binding to at least one antigen on said autologous tumor cell or said allogeneic tumor cell; and (c) binding via their Fc portion (in the case of bispecific antibodies) or via a third specificity (in the case of trispecific antibodies) to Fc receptor-positive cells, wherein there is a time interval of 1–48 hours between the administration of (1) and the administration of (2).